Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 BMS launches website to help employers support workers with multiple sclerosis FiercePharma 5 days ago
2 BMS-Ambrx collab runs out of steam after FA relaxin med canned FierceBiotech 14 days ago
3 Amid generic attack, BMS's Revlimid shows it can take a punch FiercePharma 14 days ago
4 What Is a BMS and How Do Battery Management Systems Work? MUO 8 days ago
5 Bristol Myers Squibb Teams Up with Jack and Jill of America Inc. to Expand Tomorrow's Innovators Program to Increase Black Representation in the Healthcare Industry Business Wire 20 days ago
6 Pfizer, BMS vet hits Replay with $55M seed financing, 'Big DNA' ambitions FierceBiotech 16 days ago
7 Bristol Myers Squibb partners with Jack and Jill of America to boost diversity in pharma workforce FiercePharma 12 days ago
8 Bristol Myers Squibb Bristol Myers Squibb Announces Extension of Turning Point Tender Offer 22 days ago
9 Bristol Myers' Opdivo-Yervoy combo joins Roche on the postsurgery kidney cancer flop list FiercePharma 12 days ago
10 Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights Business Wire 6 days ago
11 What To Expect From Bristol Myers Squibb Stock After Q2 Results? Forbes 22 days ago
12 Earnings season continues: BMS revenue inches up, Teva lowers outlook Medical Marketing and Media 14 days ago
13 What’s Next For Bristol Myers Squibb Stock? Forbes 2 days ago
14 Unlocking the power of AI-driven pathology in drug development: An Interview with Bristol Myers Squibb FierceBiotech 16 days ago
15 Midyear stock changes show pharma's winners and losers FiercePharma 27 days ago
16 Bristol Myers Squibb Co. stock rises Tuesday, outperforms market MarketWatch 11 hours ago
17 Battlefield Management System (BMS) Market in-Depth Analysis with Leading Key players – BAE Systems PLC, Harris Corporation, General Dynamics Corporation – Shanghaiist Shanghaiist 14 hours ago
18 Town of Meeker donates to BMS outdoor ed trip Rio Blanco Herald Times 5 days ago
19 Back To Basics: BMS holding volleyball clinic | Photos | Porterville Recorder 15 days ago
20 BMS hosts “Walk of Love” to combat violence in Jackson WJTV 25 days ago
21 BMS Re buys Mexican reinsurance broker Business Insurance 15 days ago
22 Merck & Co., Roche, and BMS Among Leading Players in the Non-Small Cell Lung Cancer Drugs Market | GlobalData Plc GlobeNewswire 21 days ago
23 Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for LAG-3-Blocking Antibody Combination Opdualag (nivolumab and relatlimab) for Treatment of Patients with Unresectable or Metastatic Melanoma Business Wire 19 days ago
24 Power Battery Management System (Bms) Market 2022 to See Huge Growth by 2029 | Key Player I, Key Player II, Key Player III, Key Player IV – Shanghaiist Shanghaiist 1 day ago
25 Batesville zoning ordinance update meeting Thursday night at BMS – WRBI Radio Country 103.9 WRBI 21 days ago
26 Electric Vehicles BMS Market Size 2022 – Huge Growth Opportunities & Expansion Till 2030 – Shanghaiist Shanghaiist 2 days ago
27 3 Unstoppable Dividend Stocks to Buy in August The Motley Fool 4 days ago
28 AbbVie's Rinvoq tops July pharma TV ad spend FiercePharma 2 days ago
29 Braemar Shipping Services (LON:BMS) Share Price Crosses Above 200-Day Moving Average of $255.69 Defense World 5 days ago
30 Peregrine Ventures announces new consortium to invest over $90 million in medical startups CTech 21 hours ago
31 Heart failure in obesity: insights from proteomics in patients treated with or without weight-loss surgery | International Journal of Obesity 1 day ago
32 Immatics Announces Second Quarter 2022 Financial Results and Business Update Yahoo Finance 21 hours ago
33 New Labs, New Funds: Activity Blossoms in the Leading U.S. Biopharma Clusters Genetic Engineering & Biotechnology News 1 day ago
34 Vitamin K Antagonists (VKA) Market 2022 Experts Review Report | Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson – Shanghaiist Shanghaiist 4 hours ago
35 Battery Management System (BMS) Chip Market 2022 Analysis by Top Leading Players | NXP, ADI, TI, ST – Shanghaiist Shanghaiist 7 days ago
36 Paclitaxel Injection Market 2022 Growth Analysis – Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E. – Shanghaiist Shanghaiist 2 hours ago
37 Myelofibrosis (MF) Market Explore Future Growth Opportunities With Top Players – Incyte, Bristol-Myers Squibb Company, Novartis AG – Shanghaiist Shanghaiist 15 hours ago
38 Bristol Myers Squibb LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York 3 months ago
39 Global Oncology Precision Medicine Market Report 2022: Featuring Key Players F. Hoffmann La Roche, Novartis, Bristol-Myers Squibb, AstraZeneca & Eli Lily and Co 23 hours ago
40 Hepatitis B Virus Treatment Market Upcoming Trends, Segmented by Type, Application, End-User and Region -Merck and Co, GlaxoSmithKline, Gilead Sciences, AbbVie Inc, Novartis AG, Bristol-Myers Squibb, Roche Holding AG – Shanghaiist Shanghaiist 19 hours ago
41 UPDATE: Bristol Myers strikes up Roche rivalry with $4.1B Turning Point buy FierceBiotech 2 months ago
42 HALOZYME THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) 11 hours ago
43 Bristol Myers Squibb Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metastatic Melanoma 5 months ago
44 Vulvovaginal Candidiasis Market 2022 Is Growing Worldwide | Effik, Bristol-Myers Squibb, Kingyork Group, Cisen Pharmaceutical – Shanghaiist Shanghaiist 1 day ago
45 Bristol Myers Squibb Bristol Myers Squibb Reports First Quarter Financial Results for 2022 3 months ago
46 Bristol Myers Squibb Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) 4 months ago
47 New Two-Year Deucravacitinib Data Reinforce Durable Efficacy and Consistent Safety Profile in Treatment of Moderate to Severe Plaque Psoriasis Bristol-Myers Squibb 3 months ago
48 Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data FierceBiotech 3 months ago
49 Lotte is telegraphing plans to grow a former BMS plant in New York FiercePharma 1 month ago
50 Immatics and BMS expand cell therapy development partnership Pharmaceutical Technology 2 months ago
51 BMS-Nektar's Opdivo combo fails phase 3 in upset to once-largest licensing deal in biotech history FierceBiotech 5 months ago
52 U.S. Food and Drug Administration Approves Camzyos™ (mavacamten) for the Treatment of Adults With Symptomatic New York Heart Association Class II-III ObstructiveHypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms Bristol-Myers Squibb 3 months ago
53 Bristol Myers Squibb Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021 6 months ago
54 Eliquis partners BMS, Pfizer double down on heart health with renewed 'No Time to Wait' campaign FiercePharma 6 months ago
55 Bristol Myers Squibb Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) with Chemotherapy as First-Line Treatment for Patients with... 4 months ago
56 Biotech buyout: San Diego's Turning Point Therapeutics sells to Bristol Myers Squibb for $4.1 billion The San Diego Union-Tribune 2 months ago
57 Did J&J and BMS conspire on blood thinner price hikes? Congressional leaders want DOJ, FTC to look into it: report FiercePharma 2 months ago
58 ASCO: BMS draws debated link for Opdivo in presurgery NSCLC FiercePharma 2 months ago
59 Bristol Myers Squibb Bristol Myers Squibb to Demonstrate the Strength of its Growing Cardiovascular Portfolio at the American College of Cardiology's 71st Annual Scientific Session 5 months ago
60 Pfizer, Alnylam and BMS: US poised for huge CV disease jump FiercePharma 1 month ago
61 Bristol Myers Squibb Bristol Myers Squibb Awards Nearly $8 Million in New Health Equity Grants to Improve Access to Care for Medically Underserved Patients in U.S. 6 months ago
62 BMS pushes for lupus trial phase 3 for TYK2 inhibitor this year FierceBiotech 2 months ago
63 Did BMS set up a subsidiary to avoid paying $1.4B in US taxes? The Senate finance chairman is on the case FiercePharma 7 months ago
64 BMS, Novartis and Roche Score New Approvals for Key Drugs BioSpace 2 months ago
65 Lymphopenia Therapeutics Market Analysis to 2022 – 2029 | AbbVie Inc, Gilead Sciences Inc, Bristol-Myers Squibb Company – Shanghaiist Shanghaiist 15 hours ago
66 Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race FierceBiotech 3 months ago
67 Testicular Cancer Drugs Market Innovative Strategy by 2029 | Bristol-Myers Squibb, Hospira, Ovation Pharmaceuticals, Teva Pharmaceutical, ZIOPHARM Oncology, Fresenius Kabi, and Others. – Shanghaiist Shanghaiist 2 days ago
68 BMS' CAR-T pressures Gilead in 2L lymphoma with broader nod FiercePharma 2 months ago
69 Checkmate plucks BMS exec Bash to be new CEO FierceBiotech 6 months ago
70 Cancer giants BMS, AstraZeneca clash in new checkpoint inhibitor patent suit FiercePharma 5 months ago
71 BMS nixes Reblozyl expansion bid in blood disorder patients who don't need frequent transfusions FiercePharma 2 months ago
72 Bristol Myers Squibb Foundation Honors Diversity and Health Equity Leader By Naming Diversity in Clinical Trials Training Program After Him; Welcomes Gilead Sciences as Program Supporter Bristol-Myers Squibb 4 months ago
73 BMS, Pfizer and Merck face steep patent cliffs but all have the financial flexibility for M&A: Moody's FiercePharma 2 months ago
74 U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag™ (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma Bristol-Myers Squibb 5 months ago
75 Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan FiercePharma 8 months ago
76 Bristol Myers Squibb to Participate in Bank of America Securities 2022 Healthcare Conference Bristol-Myers Squibb 3 months ago
77 Neoadjuvant Opdivo (nivolumab) with Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Bristol-Myers Squibb 4 months ago
78 Two Melanoma Trials Fall as BMS and Nektar Report Disappointing Results BioSpace 5 months ago
79 BMS receives US FDA approval for Camzyos to treat cardiomyopathy Pharmaceutical Technology 3 months ago
80 Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl's anemia nod FiercePharma 5 months ago
81 BMS, Merck KGaA in protein degradation race with Amphista pacts FierceBiotech 3 months ago
82 Bristol Myers sells NY biologics plant for $160M to fuel Lotte's drugmaking ambitions FiercePharma 3 months ago
83 While BMS waits for TYK2 inhibitor's psoriasis nod, a new path potentially clears in lupus FierceBiotech 3 months ago
84 Bristol Myers Squibb Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference 7 months ago
85 Bristol Myers must face a lawsuit filed by former Celgene shareholders FiercePharma 1 month ago
86 Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts FiercePharma 4 months ago
87 Bristol-Myers taps Utah Jazz player for cardiomyopathy awareness push FiercePharma 3 months ago
88 Roche, BMS to partner on personalized solutions for cancer patients 5 months ago
89 Bristol Myers Squibb Bristol Myers Squibb Presents Interim Results from Long-Term Study Reinforcing Maintenance of Response and Safety Profile of Zeposia (ozanimod) in Patients with Moderately to Severely Active Ulcerative Colitis 6 months ago
90 Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug Reuters 2 months ago
91 Berkshire Hathaway drops AbbVie and BMS FiercePharma 3 months ago
92 BMS' Revlimid revenues hit by onset of generics for the cancer drug FiercePharma 3 months ago
93 Bristol Myers Squibb research reveals atomic structure of protein receptor CD47 Drug Target Review 7 months ago
94 'We Take Care of Our BMS Family' Bristol Myers Squibb Canc 4 months ago
95 5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy The Motley Fool 4 months ago
96 BMS Enlists Owkin's AI/ML Tech to Improve Clinical Trials BioSpace 2 months ago
97 How a BMS schizophrenia candidate might work in Alzheimer's FierceBiotech 2 months ago
98 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer Bristol-Myers Squibb 5 months ago
99 Bristol Myers Squibb Bristol Myers Squibb Announces Positive Topline Results from Phase 3 VALOR-HCM Trial, Evaluating Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy Who are Eligible for Septal Reduction Therapy 6 months ago